View Older Stories View More Recent Stories
-
Agilent Technologies (A) names Pascal Soriot and Judy Gawlik Brown to Board
-
Agilent (A) PT Lowered to $116 at Jefferies
-
Agilent Technologies (A) European IVDR Certification for Companion Diagnostic Assay in Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma
-
Evercore Adds 7 Names to Tactical Outperform List
-
Agilent Technologies (A) xCELLigence RTCA Instrumentation Applied in Recent FDA Approval
-
TD Cowen: 'Top 10 Themes Coming Out of 45th Annual Health Care Conference'
-
Agilent Technologies (A) PD-L1 IHC 28-8 pharmDx Receives EU IVDR Certification as a Companion Diagnostic Test for Non-small Cell Lung Cancer and Melanoma Indications
-
Stifel Reiterates Buy Rating on Agilent (A)
-
Stocks expected to have increasing option volume: A SG VAC BYND MRNA JOBY SRPT SPCE
-
Agilent Technologies (A) Tops Q1 EPS by 4c, Beats on Revenue; Offers Guidance
-
Agilent Technologies (A) spreader active in March 125 puts, March 135 puts and March 145 calls into quarter results
-
Agilent Technologies (A) call put ratio 2.4 calls to 1 put
-
Agilent Technologies (A) Declares $0.248 Quarterly Dividend; 0.7% Yield
-
TD Cowen: 'Assessing Impact of US Ban on China Exports for LCMS & Flow Cyt Instruments'
-
Agilent Technologies (A) call put ratio 1 call to 2 puts with a focus on January 140 puts as share price down 1.3%
-
Waters Corp. (WAT), Others Decline on Concerns about New Export Controls on Biotech Equipment
-
Stifel Reiterates Buy Rating on Agilent (A); 'As Far as Shares Go, We Remain Positively Inclined for 2025'
-
Baird Reiterates Outperform Rating on Agilent (A)
-
Bernstein SocGen Group Reiterates Market Perform Rating on Agilent (A) Following Investor Day
-
Agilent Technologies (A) on watch ahead of Investor Day
-
Agilent (A) Companion Diagnostic Assay PD-L1 IHC 28-8 pharmDx Receives European IVDR Certification
-
TD Cowen Reiterates Buy Rating on Agilent (A)
-
Agilent (A) PT Lowered to $135 at Bernstein SocGen Group
-
Baird Reiterates Outperform Rating on Agilent (A)
-
After-hours movers: Zoom, Agilent, HanesBrands, Kohl's
-
Agilent Technologies (A) Tops Q4 EPS by 5c, Offers Guidance
-
Agilent Technologies (A) Announces New Organizational Structure
-
Agilent Technologies (A) call put ratio 1.3 calls to 1 put into quarter results
-
Agilent Technologies (A) call put ratio 1 call to 1.4 puts into quarter results
-
Agilent Technologies (A) Raises Quarterly Dividend 5.5% to $0.248; 0.8% Yield
-
Citi Reiterates Buy Rating on Agilent (A)
-
Agilent Technologies (A) Completes Acquisition of BIOVECTRA
-
Agilent Technologies (A) Declares $0.236 Quarterly Dividend; 0.7% Yield
-
Agilent Technologies (A) Unveils Biopharma CDx Services Lab to Accelerate Precision Medicine
-
Agilent Technologies (A) Files for Debt Offering
-
KeyBanc Reiterates Sector Weight Rating on Agilent (A)
-
Agilent (A) PT Raised to $160 at TD Cowen
-
Agilent (A) PT Raised to $147 at BofA Securities
-
Agilent (A) PT Raised to $135 at Evercore ISI
-
Agilent (A) PT Raised to $165 at Citi
-
Agilent Technologies (A) Tops Q3 EPS by 6c; revises guidance
-
Agilent Technologies (A) call put ratio 2.7 calls to 1 put into quarter results
-
Agilent Technologies (A) September straddle priced into quarter results
-
Agilent Technologies (A) Receives FDA Approval for MAGE-A4 IHC 1F9 pharmDx as a Diagnostic Tool for Use with Newly Approved TCR T-Cell Therapy
-
Agilent Technologies (A) Acquires Sigsense
-
Jefferies Reiterates Hold Rating on Agilent (A)
-
Agilent Technologies (A) to Acquire BIOVECTRA
-
10 policies if Trump wins and stock implications: Jefferies
-
Life Science Tools & Diagnostics stocks: Q2 earnings preview
-
Agilent Technologies (A) Appoints Bret DiMarco as Chief Legal Officer

